Skip to content
Insights
All Insights
In My Opinion
In Your Practice
Patient Populations
News
All News
Recent Updates
FDA Approvals
Clinical Trials
Conference Correspondent
Explore by Topic
All Topics
Cancer Types
Therapeutic Approaches
Diagnostics & Biomarkers
Multimedia
All Media
Videos
Podcasts
Subscribe
Insights
All Insights
In My Opinion
In Your Practice
Patient Populations
News
All News
Recent Updates
FDA Approvals
Clinical Trials
Conference Correspondent
Explore by Topic
All Topics
Cancer Types
Therapeutic Approaches
Diagnostics & Biomarkers
Multimedia
All Media
Videos
Podcasts
Subscribe
Subscribe
Real Clinics. Real Patients. Real Oncology.
Home
/
Tags
/
ASCO 2026
Home /
ASCO 2026
ASCO 2026
ASCO 2026
Recent Updates
Daraxonrasib Improves Survival Outcomes in Previously Treated Metastatic PDAC
June 1, 2026
Recent Updates
Improving Disease Control in Dedifferentiated Liposarcoma
June 1, 2026
Recent Updates
Adjuvant Selpercatinib Improves Outcomes in RET-Positive Early-Stage NSCLC
June 1, 2026
Recent Updates
Ivonescimab Plus Chemotherapy Extends OS in Advanced Squamous NSCLC
June 1, 2026
Recent Updates
PROTEUS Supports Perioperative Apalutamide Plus ADT for High-Risk Prostate Cancer
June 1, 2026
Recent Updates
Daraxonrasib Improves Survival Outcomes in Previously Treated Metastatic PDAC
June 1, 2026
Recent Updates
Improving Disease Control in Dedifferentiated Liposarcoma
June 1, 2026
Recent Updates
Adjuvant Selpercatinib Improves Outcomes in RET-Positive Early-Stage NSCLC
June 1, 2026
Recent Updates
Ivonescimab Plus Chemotherapy Extends OS in Advanced Squamous NSCLC
June 1, 2026
Recent Updates
PROTEUS Supports Perioperative Apalutamide Plus ADT for High-Risk Prostate Cancer
June 1, 2026
News & Insights
Recent Updates
Daraxonrasib Improves Survival Outcomes in Previously Treated Metastatic PDAC
June 1, 2026
Recent Updates
Improving Disease Control in Dedifferentiated Liposarcoma
June 1, 2026
Recent Updates
Adjuvant Selpercatinib Improves Outcomes in RET-Positive Early-Stage NSCLC
June 1, 2026
Recent Updates
Ivonescimab Plus Chemotherapy Extends OS in Advanced Squamous NSCLC
June 1, 2026
Recent Updates
PROTEUS Supports Perioperative Apalutamide Plus ADT for High-Risk Prostate Cancer
June 1, 2026
Podcasts
No results were found
What are you looking for?
Search
Search
POPULAR SEARCHES
Bladder Cancer
Blood-Based Tests
Breast Cancer
Cancer Types
